An open randomized controlled trial to compare the efficacy of two fixed dose combinations of artemesinin based combinations for uncomplicated falciparum malaria in Bangladesh

Bangladesh Medical Research Council Bulletin

Volumn 39, Issue 3, 2013, Pages 109-115

  Samad, R ^a   Rahman, M R ^a   Yunus, E B ^a   Hussain, M A ^a   Arif, S M ^b   Islam, M N ^c   Samma, Hafiz ^d   Hossain, M M ^c   Faiz, M A ^a  

^a Malaria Research Group (MRG)   (Bangladesh)

^b DHAKA MEDICAL COLLEGE   (Bangladesh)

^c National Malaria Control Programme (MNCP)   (Bangladesh)

^d Department of Medicine Combined Military Hospital (CMH)   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; AMODIAQUINE; AMODIAQUINE, ARTESUNATE DRUG COMBINATION; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BANGLADESH; CHILD; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MULTIDRUG RESISTANCE; OPEN STUDY; PARASITE CLEARANCE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT RESPONSE; COMPARATIVE STUDY; DRUG COMBINATION; MALARIA, FALCIPARUM; MIDDLE AGED; PRESCHOOL CHILD; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; BANGLADESH; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907166466     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: 10.3329/bmrcb.v39i3.20310     Document Type: Article

References (20)

1. Malaria and Parasitic Disease Control Unit, Dhaka, Bangladesh. 2004; unpublished report.
2. Rosenberg R. Forest malaria in Bangladesh. III. Breeding habits of Anopheles dirus. American Journal of Tropical Medicine and Hygiene. 1982; 31: 192-201.
3. Malaria and Parasitic Disease Control Unit, Dhaka, Bangladesh. 1995; unpublished report.
4. Bangali AM, Rahman MR. Bangladesh Country Report presented in the "Training Workshop on Monitoring of Therapeutic Efficacy of Antimalarial Drugs against Falciparum Malaria". 13-17 January, 1997; Anuradhapura, Srilanka. (not published).
5. Waiz A . Editorial. Malaria: Magnitude of the problem in Bangladesh. Bangladesh Medical Journal. 1984; 13(2&3): I-IV.
6. Faiz MA, Ahmed M. In-vivo assessment of the sensitivity of Plasmodium falciparum to single dose pyremethamine-sulfadoxine in Bangladesh where chloroquine resistant falciparum malaria has been detected. J. Bang. Col. Phys. Surg. 1986; 4 : (1): 7-9.
7. Rahman MR, Hassan MR, Faiz MA, Samad R, Paul B & Jalil MA. Monitoring efficacy of commonly used antimalarials by a 14-day in-vivo test in a new settler's camp in endemic zone at Cox's Bazar. Bangladesh Medical Research Council. 1998; 24(3): 67-74.
8. Rahman MR, Paul DC, Rashid M, Ghosh A, Bangali AM, Jalil MA, Faiz MA. A randomized controlled trial on the efficacy of alternative treatment regimens for uncomplicated falciparum malaria in a multidrug-resistant falciparum area of Bangladesh - narrowing the options for the National Malaria Control Program?. Transactions of Royal Society of Tropical Medicine and Hygiene. 2001; 95: 661-667.
9. Noedl H, Faiz MA, Yunus EB, Rahman MR, Hossain MA, Samad R, Miller RS, Pang LW, Wongsrichanalai C. Drug resistant malaria in Bangladesh: an in vitro assessment American Journal of Tropical Medicine and Hygiene. 2003; 68(2): 140-142.
10. Rahman, M., Rahman, MR., Bangali, AM, Das S, Talukder, MR, Ringwald P. Efficacy of combined chloroquine and sulfadoxine-pyrimethamine in uncomplicated Plasmodium falciparum malaria in Bangladesh. Transaction of Royal Society of Tropical Medicine and Hygiene. 2004; 98(7): 438-441.
11. Borek IV, Maung UA, Peters A, Liem L, Kamal M, Rahman M, Rahman MR, Bangali AM, Dash S, Barends M, Faiz AM. Efficacy of combined chloroquine and sulfadoxine-pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tract, Bangladesh. Transaction of Royal Society of Tropical Medicine and Hygiene. 2005; 99: 727-735.
12. World Health Organization. Guidelines for malaria treatment.[http://www.who.int/malaria/docs/ Treatment Guidelines 2006. pdf].
13. Arrow J, Panosian CB, Gelband H, (Eds): Saving lives, buying time: Economics of malaria drugs in an age of resistance. Washington DC, USA:National Academy Press; 2004.
14. Rahman MR, Dondorp AM, Day NPJ, Lindegardh N, Imwong M, Faiz MA, Bangali AM, Kamal ATM, Karim J, Kaewkungwal J, Singhasivanon P. Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Transactions of Royal Society of Tropical Medicine &Hygiene. 2008; 102 (9): 861-867.
15. Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O. Randomized, multicentre assessment of the efficacy and safety of ASAQ - a fixed-dose artesunate-amodiaquine combination therapyin the treatment of uncomplicated P. falciparum malaria. Malaria Journal. 2009; 8:125.
16. Sirima SB,Tiono AB, Gansané A, Diarra A, Ouédraog A, Konaté AT, Kiechel JR, Morgan CC, Olliaro PL, Taylor WRJ. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young children with acute uncomplicated Plasmodium falciparum. Malaria Journal. 2009; 8:48.
17. World Health Organization. Facts on ACTs; January 2006 update.
18. Bonnet M, Broek IVD, Herp MV, Urrutias PPP, Kyomuhendo J, Ndosimao CN, Ashley E, Guthmann JP. Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies. Malaria Journal. 2009; 8:192.
19. Ndiaye J, Faye B, Gueye A, Tine R, Ndiaye D, Tchania C, Ndiaye I, Barry A, Cisse B, Lameyre V, Gaye O. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Malaria Journal 2011; 10:237.
20. SANOFI-AVENTIS. Application for an inclusion in the WHO essential drug list-subdivision 6.5.3 antimalarial medicines-curative treatments; April 2006.